Literature DB >> 17506235

Epidemiology and direct medical costs of human leishmaniasis in Italy.

A Mannocci1, G La Torre, G Chiaradia, C De Waure, M T Mainelli, A Cernigliaro, S Bruno, W Ricciardi.   

Abstract

INTRODUCTION: In the last decades, visceral Leishmaniasis infection rate has increased in Western Mediterranean areas. Epidemiological data show that in Italy, especially in some regions, the prevalence of canine form is high. The aim of this study is to evaluate the epidemiological setting of Leishmaniasis in Italy, according to age groups and geographical areas, and to estimate the associated direct medical costs.
METHODS: The study examined the ordinary and day-hospital discharges and the respective mean of hospital length of stay for Leishmaniasis and visceral Leishmaniasis in Italy, during the period 1999-2003. Moreover, we collected data about notifications of Leishmaniasis, from 1993 to 2004, and mortality due to this infectious disease, from 1993 to 1998. We evaluated the prevalence rates of discharges, the visceral and cutaneous Leishmaniasis notifications incidence rates and the mortality rates from disease, per 1,000,000 residents. Costs analysis was performed getting DRG number 423 rate, which corresponds to "other diagnosis related to infectious and parasitary diseases".
RESULTS: Ordinary discharges decreased in the study period, while day-hospital discharges increased. Sicilia, Campania and Lazio regions showed the highest number of ordinary hospital discharges for Leishmaniasis (prevalence rates were respectively 16.29, 15.02 and 12.83 per 1,000,000 residents, in 2003). Campania and Sicilia showed also the highest prevalence rates of day-hospital discharges (respectively 17.29 and 35.39 per 1,000,000 residents in 2003). The analysis of incidence rates of notifications showed a cyclic trend of the visceral form of the disease, with the highest rates observed in the group aged 0-14 years (incidence rates per 1,000,000: 7.46 in 1996 and 8.59 in 2000). The highest mortality rates were observed in the group aged over 65 years; low but constant mortality rates for Leishmaniasis were seen in the age group 25-64 years. Direct costs for both ordinary and day-hospital admissions were: 1,561,218.46 Euro in 1999; 1,637,256.44 Euro in 2000; 1,459,892.92 Euro in 2001, 1,468,983.58 Euro in 2002 and 1,370,227.80 Euro in 2003. DISCUSSION: Discharges for Leishmaniasis showed non-homogeneous trend in Italy, especially in coastal Regions. Leishmaniasis notifications have slowly increased after 1993 and a high number of notifications was observed in the 0-14 years old group. The highest mortality rates were reported in the extreme age-groups: mortality was relevant for patients over 65 years. Moreover, cost analysis showed that health care of human Leishmaniasis requires long time of hospitalization with consequent high costs. Conclusion. Preventive measures have to be turned to extreme age groups. For future studies issues such as high costs of treating disease, cost-effectiveness evaluation of the 'current therapeutic approach compared to preventive interventions on dogs and vector insects would be of interest.

Entities:  

Mesh:

Year:  2007        PMID: 17506235

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


  5 in total

1.  Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic.

Authors:  Alberto Biglino; Cesare Bolla; Erika Concialdi; Anna Trisciuoglio; Angelo Romano; Ezio Ferroglio
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

2.  Impact of self-financed rotavirus vaccines on hospital stays and costs in Spain after a 3-year introductory period.

Authors:  O Redondo-González; J M Tenías-Burillo; J Ruiz-Gonzalo
Journal:  Epidemiol Infect       Date:  2017-04-03       Impact factor: 4.434

3.  A nationwide survey of Leishmania infantum infection in cats and associated risk factors in Italy.

Authors:  Roberta Iatta; Tommaso Furlanello; Vito Colella; Viviana Domenica Tarallo; Maria Stefania Latrofa; Emanuele Brianti; Paolo Trerotoli; Nicola Decaro; Eleonora Lorusso; Bettina Schunack; Guadalupe Mirò; Filipe Dantas-Torres; Domenico Otranto
Journal:  PLoS Negl Trop Dis       Date:  2019-07-15

4.  Epidemiologic-economic models and the One Health paradigm: echinococcosis and leishmaniasis, case studies in Veneto region, Northeastern Italy.

Authors:  Massimo Canali; Maurizio Aragrande; Andrea Angheben; Gioia Capelli; Michele Drigo; Federico Gobbi; Francesca Tamarozzi; Rudi Cassini
Journal:  One Health       Date:  2019-11-27

5.  Canine leishmaniasis in Southern Italy: a role for nitric oxide released from activated macrophages in asymptomatic infection?

Authors:  Maria A Panaro; Olga Brandonisio; Donato de Caprariis; Pasqua Cavallo; Antonia Cianciulli; Vincenzo Mitolo; Domenico Otranto
Journal:  Parasit Vectors       Date:  2008-05-09       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.